This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 26 May 2014  |  Asia Pacific  |  Market Research

    Indonesian Infectious Disease IVD Market

    Mapping the Market for Investment, Best Practices, and Growth Potential

    The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...

    $4,950.00
  2. 23 May 2014  |  Asia Pacific  |  Market Research

    Western European Companion Diagnostics Market

    Regulatory Hurdles and LDTs Stall the Global and European Market for Companion Diagnostics

    The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a signi...

    $4,950.00
  3. 20 May 2014  |  Asia Pacific  |  Market Research

    Russia In Vitro Diagnostics (IVD) Market Data

    Early Detection Provides New Opportunities for IVD Industry

    This study provides data for the Russian in vitro diagnostics (IVD) market. Hematology, hemostasis (coagulation), urinalysis, microbiology, clinical chemistry, point of care testing, molecular diagnostics, immunochemistry, and others namely, tissue diagnostics and self-monitoring blood glucose, are the segments discussed in this market. Market reve...

    $3,950.00
  4. 05 May 2014  |  Asia Pacific  |  Market Research

    Russia Hematology Diagnostics Market Data

    Russian Governments Support for Development of In Vitro Diagnostic Industry Propels Adoption of High End Analyzers

    This study provides market data for the Russian hematology diagnostics market. Segments in the market include instruments and reagents. Instruments are further segmented by 5PD and 3PD analyzers. Market revenues, installed base units, and market share are included in this deliverable. Further analysis is provided in a separate deliverable to accomp...

    $3,950.00
  5. 05 May 2014  |  Asia Pacific  |  Market Research

    Russia Urinalysis Market Data

    Increase in Test Volume Creates a Favorable Market for Reagents

    This study provides market data for the Russian urinalysis market. Market segments include sediment, dipstick, and integrated systems. Sediment and dipstick segments are further segmented by instruments and reagents. Integrated systems is further segmented by instruments. In this deliverable, market revenues, installed base units, and market share ...

    $3,950.00
  6. 05 May 2014  |  Asia Pacific  |  Market Research

    Russia Hemostasis Market Data

    Russian Governments Intensive Support for Development of the In vitro Diagnostics Industry Propels Adoption of High-end Analyzers

    This study provides market data for the Russian hemostasis diagnostics market. Market segments include instruments and reagents. The study also includes market revenues, installed base units, and market share for hemostasis diagnostics. Further analysis is provided in a separate deliverable to accompany this data. The timeframe for this study is 20...

    $3,950.00
  7. 27 Mar 2014  |  Asia Pacific  |  Market Research

    2013 APAC Healthcare Outlook

    Changing Dynamics to Disrupt and Transform Healthcare in Asia-Pacific by 2018

    Healthcare expenditure in Asia-Pacific is expected to continue growing over the next 6 years, as rising demand for better healthcare for patients spurs reforms. This would also increase life expectancy, resulting in a large elderly population requiring long-term care. This study covers the hospital, life sciences, advanced medical technology, and c...

    $2,450.00
  8. 21 Mar 2014  |  Asia Pacific  |  Market Outlook

    Asia-Pacific Healthcare Outlook - 2014

    Changing Landscape Impacting Lives

    The study presents an outlook of the healthcare market in the Asia-Pacific. Good healthcare service can impact social issues, economics, and even the politics of a country. Governments need to meet these expectations, but rising costs in population and demographic shifts are causing them to falter. Disparity in care levels is also a concern, especi...

    $4,950.00
  9. 27 Feb 2014  |  Asia Pacific  |  Market Research

    Product and Pipeline Assessment of the Global Orphan Drugs Market

    Attractive Market Lures Hundreds of Innovators, Large and Small

    The global market for vaccines is estimated to be only 2-3% of the total pharmaceuticals market in 2014; however, this sector has been continuously experiencing a stellar growth rate of 10-15% per year versus the 5-7% seen in the overall market. Currently, the most commonly available vaccines are administered by injection, which makes mass immuniza...

    $3,950.00
  10. 12 Feb 2014  |  Asia Pacific  |  Market Research

    Private Equity and Venture Capital Investment in the Global Pharmaceutical and Biotechnology Industry

    Vigilance and Equanimity are the Needs of the Hour

    The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0%...

    $4,950.00